| Factor Information | |
|---|---|
| Data ID | 1893 |
| Factor | Year of catheterization |
| Description | Year of catheterization had an odds ratio of 0.97 (95% CI: 0.95–1.00, P = .03). |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | with transcatheter interventions in congenital heart disease and examine predictors for adverse events. |
| p Value | 0.03 |
| OR | 0.97 |
| Conclusion | We found an increase in number of procedures over time and a decrease in frequency of adverse events. Higher procedure-type risk categories were associated with increased risk of adverse events. |
| Risk Factor | protective factor |
| CHD Type | |
|---|---|
| ID | 562 |
| CHD Type | isolated CHD |
| CHD Subtype | PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
| Reference | |
|---|---|
| PMID | 25196278 |
| Year | 2015 |
| Title | Adverse events in transcatheter interventions for congenital heart disease: a population-based long-term study |
| Sample | ||
|---|---|---|
| Population | All | |
| Source | N/A | |
| Region | Aarhus, Denmark | |
| Method | N/A | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | Transcatheter Interventions | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | 1595 | N/A |
| Age | Age, median (IQR): 5.3 (1.1–22.3) | N/A |
| Gender (Male: Female) | 759:836 | N/A |
| Marker Level | N/A | N/A |
